Pharmacogenomic testing in depression has limited evidence base so far

Pharmacogenomic testing to inform the selection of an antidepressant has demonstrated limited evidence of effectiveness thus far, concludes a systematic review published online Jan. 3 in the Journal of Clinical Psychiatry. The relevant studies that have been conducted to this point have been weakened by methodological limitations and significant bias, researchers stated.

Source: The Brown University Psychopharmacology Update - March 23, 2017 Category: Psychiatry Tags: Depression Treatment Source Type: research